6.18 USD
↘ 0.13 (2.12%)LIVE (AS OF 03:22 PM EDT)
Kyntra Bio, Inc. Common Stock
KYNBNASDAQ • USD
Market: OPEN
Kyntra Bio, Inc. Common Stock (KYNB) trades at $6.18 per share. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, KYNB appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 2, 2026.
Open?$6.36
High?$6.56
Low?$5.70
Prev. Close?$6.31
Volume?83.2K
Avg. Volume?25.3K
VWAP?$6.05
Rel. Volume?3.29x
Bid / Ask
Bid?$5.16 × 100
Ask?$7.35 × 100
Spread?$2.19
Midpoint?$6.26
Valuation & Ratios
Market Cap?25.5M
Shares Out?4.0M
Float?3.9M
Float %?95.7%
P/E Ratio?0.14
P/B Ratio?-0.85
EPS?$45.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Themes
Employees
34
Market Cap
25.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-11-14
Address
350 BAY STREET
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?2.60%Low
Short Interest?100.7K
Days to Cover?4.3
Free Float3.9M
Avg Daily Volume23.7K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.69Strong
Quick Ratio?2.59Strong
Cash Ratio?1.41Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score93/100
P/E?0.1CHEAP▾
Peers100
S&P97
P/B?-0.85CHEAP▾
S&P97
P/S?5.53FAIR▾
Peers100
S&P25
P/FCF?N/A▾
EV/EBITDA?0.5CHEAP▾
Peers100
S&P97
EV/Sales?-5.44CHEAP▾
S&P97
Returns & Efficiency
ROE?-607.7%WEAK▾
S&P3
ROA?181.2%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-38062000
Enterprise Value?$-25094028
Fundamentals ratios updated end of day